Alterity Therapeutics LTD (PRNAF)
PRNAF is quoted over the counter, not listed on an exchange. Alterity Therapeutics LTD files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | PRNAF, quoted over the counter |
| SEC CIK | 0001131343 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Melbourne |
| Incorporated in | Australia |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-08-28 |
| Cash and burn | 37.3M AUD cash; operating cash flow -5.6M AUD a quarter. | Report 2026-06-30 |
| Shares outstanding | 18,125,739 (2026-06-30); 760,614,224 a year earlier; 203,324,802 three years earlier. share count fell by more than half since 2025-06-30 with no split on record, which usually means a reverse split; 1y dilution not computed; share count fell by more than half since 2023-06-30 with no split on record, which usually means a reverse split; 3y dilution not computed. | Cover page 2026-06-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers, Melbourne, Australia | PCAOB Form AP 2026-09-14 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $24K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2026 2026-06-30 | Not filed | -23.4M AUD | -22.5M AUD | 37.3M AUD | No debt tags | Needs four quarters | 20-F 2026-08-28 |
| FY 2025 2025-06-30 | Not filed | -12.1M AUD | -11.5M AUD | 33.2M AUD | No debt tags | Needs four quarters | 20-F 2025-08-29 |
| FY 2024 2024-06-30 | Not filed | -19.1M AUD | -12.6M AUD | 12.6M AUD | No debt tags | Needs four quarters | 20-F 2025-08-29 |
| FY 2023 2023-06-30 | Not filed | 13.8M AUD | -20.0M AUD | 15.8M AUD | No debt tags | Needs four quarters | 20-F 2023-08-31 |
| FY 2022 2022-06-30 | Not filed | 12.8M AUD | -12.3M AUD | 34.8M AUD | No debt tags | Needs four quarters | 20-F 2023-08-31 |
| FY 2021 2021-06-30 | Not filed | 15.3M AUD | -17.3M AUD | 28.1M AUD | No debt tags | Needs four quarters | 20-F 2023-08-31 |
| FY 2020 2020-06-30 | Not filed | 13.5M AUD | -9.4M AUD | 9.2M AUD | No debt tags | Needs four quarters | 20-F 2022-08-31 |
| FY 2019 2019-06-30 | Not filed | 12.3M AUD | -14.0M AUD | 14.4M AUD | No debt tags | Needs four quarters | 20-F 2021-09-02 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in AUD.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2024-02-15 |
| Latest annual report | 20-F | 2026-08-28 |
| Latest quarterly / interim | 6-K | 2026-11-12 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier